XML 18 R8.htm IDEA: XBRL DOCUMENT v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash flows from operating activities:    
Net income $ 21,853 $ 59,786
Depreciation and amortization 153,821 144,925
Other operating activities and non-cash items 5,967 14,100
Changes in assets and liabilities (157,492) (56,499)
Net cash provided by operating activities 24,149 162,312
Cash flows from investing activities:    
Payments for property, plant and equipment (79,897) (96,169)
Proceeds from sale of property, plant and equipment 4,209 3,439
Proceeds from foreign exchange forward contracts 16,674 740
Payments for foreign exchange forward contracts (15,992) (24,596)
Payments for short-term investments (169,720) (111,760)
Proceeds from sale of short-term investments 32,345 16,014
Proceeds from maturities of short-term investments 147,825 121,684
Other investing activities 1,502 4,545
Net cash used in investing activities (63,054) (86,103)
Cash flows from financing activities:    
Proceeds from short-term debt 0 5,012
Payments of short-term debt 0 (5,669)
Payments of long-term debt (25,493) (29,100)
Payments of finance lease obligations (15,659) (19,684)
Payments of dividends 0 (19,383)
Other financing activities (1,099) (1,053)
Net cash used in financing activities (42,251) (69,877)
Effect of exchange rate fluctuations on cash, cash equivalents and restricted cash 5,172 (8,164)
Net decrease in cash, cash equivalents and restricted cash (75,984) (1,832)
Cash, cash equivalents and restricted cash, beginning of period 1,134,312 1,120,617
Cash, cash equivalents and restricted cash, end of period 1,058,328 1,118,785
Non-cash investing and financing activities:    
Property, plant and equipment included in capital expenditures payable 202,242 195,405
Dividends declared and unpaid 20,423  
Right of use assets acquired through operating lease liabilities 395 2,321
Right of use assets acquired through finance lease liabilities 10,645 17,811
Grants and incentive receivables for qualified capital expenditures $ 2,939 $ 0